Horst Hummel

422 total citations
4 papers, 326 citations indexed

About

Horst Hummel is a scholar working on Pathology and Forensic Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Horst Hummel has authored 4 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pathology and Forensic Medicine, 3 papers in Oncology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Horst Hummel's work include Lymphoma Diagnosis and Treatment (4 papers), CAR-T cell therapy research (3 papers) and Immune Cell Function and Interaction (2 papers). Horst Hummel is often cited by papers focused on Lymphoma Diagnosis and Treatment (4 papers), CAR-T cell therapy research (3 papers) and Immune Cell Function and Interaction (2 papers). Horst Hummel collaborates with scholars based in Germany and United States. Horst Hummel's co-authors include Max S. Topp, Achim Rothe, Elke Pogge von Strandmann, Stephanie Sasse, Stefan Knackmuss, Peter Borchmann, M. Ravic, Georg Kuhnert, Andreas Engert and Markus Dietlein and has published in prestigious journals such as Blood and Blood Advances.

In The Last Decade

Horst Hummel

4 papers receiving 314 citations

Peers

Horst Hummel

ONCOL

IMMUN

PFM

RNMI

MB

Keith Fay Australia

Dena DeMarco United States

Marie-Elisabeth Goebeler Germany

Rodica Morariu-Zamfir United States

Linda Lundberg Switzerland

Timothy Voorhees United States

Florian Eisele Germany

James Relf Switzerland

Mahan Moshir Belgium

Nairouz Elgeioushi United States

Keith Fay Australia

Horst Hummel

230 ×0.9

ONCOL

70 ×0.4

IMMUN

162 ×1.2

PFM

93 ×0.8

RNMI

33 ×0.7

MB

Citations per year, relative to Horst Hummel Horst Hummel (= 1×) peers Keith Fay

Countries citing papers authored by Horst Hummel

Since Specialization

Citations

This map shows the geographic impact of Horst Hummel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Horst Hummel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Horst Hummel more than expected).

Fields of papers citing papers by Horst Hummel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Horst Hummel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Horst Hummel. The network helps show where Horst Hummel may publish in the future.

Co-authorship network of co-authors of Horst Hummel

This figure shows the co-authorship network connecting the top 25 collaborators of Horst Hummel. A scholar is included among the top collaborators of Horst Hummel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Horst Hummel. Horst Hummel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Sayehli, Cyrus, Manik Chatterjee, Horst Hummel, et al.. (2019). Long-term outcome of patients with relapsed/refractory B-cell non-Hodgkin lymphoma treated with blinatumomab. Blood Advances. 3(16). 2491–2498. 65 indexed citations

2.

Rothe, Achim, Stephanie Sasse, Max S. Topp, et al.. (2015). A phase 1 study of the bispecific anti-CD30/CD16A antibody construct AFM13 in patients with relapsed or refractory Hodgkin lymphoma. Blood. 125(26). 4024–4031. 253 indexed citations

3.

Zhukovsky, Eugene A., Achim Rothe, Bastian von Tresckow, et al.. (2013). A Phase I Study Of An Anti-CD30 x Anti-CD16A Bispecific Tandab Antibody, AFM13, In Patients With Relapsed Or Refractory Hodgkin Lymphoma. Blood. 122(21). 5116–5116. 3 indexed citations

4.

Rothe, Achim, Anas Younes, Katrin S. Reiners, et al.. (2011). A Phase I Study with the Bispecific Anti-CD30 × Anti-CD16A Antibody Construct AFM13 in Patients with Relapsed or Refractory Hodgkin Lymphoma,. Blood. 118(21). 3709–3709. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact